PHILADELPHIA--(BUSINESS WIRE)--Dec. 12, 2005--Hemispherx Biopharma, Inc. (AMEX: HEB) announced that Dr. William A. Carter, Chairman & CEO, will present at the New York Society of Security Analysts (NYSSA) 9th Annual Healthcare Industry Conference Thursday, December 15th at 11:20am EST. In the presentation, Dr. Carter will be reviewing the various achievements and progress the Company has made throughout the year. The Company has recently entered into clinical trials with their experimental products Ampligen, Alferon N, Alferon LDO (Low Dose Oral) against Avian Influenza as a stand-alone antivirals and vaccine adjuvant to expand available supplies. These global based trials will be highlighted in the presentation.
